Find out how Amgen is transforming their antibody discovery and clonal cell line processes with the Berkeley Lights Platform.

Please fill out the following form to access this resource:

First Name*
Last Name*
Email Address*
Phone Number*
City*
Country*
State*
Company/Institute*
CAPTCHA

Related Resources

View All Resources

Antibody Discovery

App Note: Discover Lead Molecules Against Difficult Targets Inaccessible by Hybridoma Methods

Download this application note to learn about how the Opto™ Plasma B Discovery workflow increases hit recovery for difficult membrane-bound targets and provides access to greater sequence diversity when compared to traditional hybridoma methods.

Cell Line Development

Brochure: Increase CDMO Revenue with the Opto CLD Workflow

Find our how the Opto CLD workflow sets a new standard for quality, capacity, and speed in cell line development and allows CDMOs to scale operations and drive new business.

Cell Line Development

Customer Spotlight: Catalent on CLD

Find out how Catalent Biologics is able to select significantly higher expressing clonal cell lines with the Opto CLD workflow.